Piskel Kyle (CIK 0001780662)

Latest company ownership

Shares held
94,384
Last filed at
Dec 2, 2025
Confidence Score
22.8
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 28, 2025 Dec 2, 2025 Adaptive Biotechnologies Corp CFO Sell 5.0 -162,820 -42.91% ✓ $3.2M
Nov 17, 2025 Nov 18, 2025 Adaptive Biotechnologies Corp CFO Sell 52.5 -238 -0.09% ✗ $3.3K
May 16, 2025 May 20, 2025 Adaptive Biotechnologies Corp CFO Sell 48.8 -1,929 -0.71% ✗ $17.1K
May 15, 2025 May 19, 2025 Adaptive Biotechnologies Corp CFO Sell 78.8 +5,886 2.17% ✗ $17.1K
Mar 4, 2025 Mar 6, 2025 Adaptive Biotechnologies Corp CFO Sell 95.0 +114,680 74.31% ✗ $72.1K
Nov 18, 2024 Nov 19, 2024 Adaptive Biotechnologies Corp CFO Sell 52.5 -248 -0.16% ✗ $1.2K
Mar 4, 2024 Mar 6, 2024 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 91.3 +36,013 41.25% ✗ $26.5K
Nov 16, 2023 Nov 20, 2023 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 52.5 -259 -0.30% ✗ $1.1K
Mar 6, 2023 Mar 8, 2023 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 91.3 +40,206 84.90% ✗ $30.2K
Nov 16, 2022 Nov 17, 2022 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 50.0 -307 -0.64% ✗ $2.7K
Nov 16, 2022 Nov 17, 2022 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 47.5 -959 -2.01% ✗ $8.5K
Mar 4, 2022 Mar 8, 2022 Adaptive Biotechnologies Corp Principal Accounting Officer Sell 90.0 +40,966 611.52% ✗ $2.6K